ARS Pharmaceuticals, Inc. ($SPRY)
RA CAPITAL MANAGEMENT, L.P. โ Director
Shares
30,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | RA CAPITAL MANAGEMENT, L.P. |
|---|---|
| Title | Director |
| Transaction Date | Jun 24, 2026 |
| Expiration Date | Jun 23, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | See Footnotes |
| Filing Date | Jun 26, 2026 |
| Shares Purchased | 30,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 30,000 |
| Derivative | Derivative |
| Accession Number | 0001231919-26-000704 |
| Document | View SEC Filing |